详情页 - 首都医科大学附属北京同仁医院知识库

资源类型：

文章类型：

作者：

Gao, Ming[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] * ; Chi, Yihebali[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Zheng, Xiangqian[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Li, Dapeng[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17]

; Tang, Pingzhang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Xu, Zhengang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Chen, Xiaohong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17]

; Ge, Minghua[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Zhang, Yuan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Guo, Zhuming[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Wang, Jun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Chen, Jie[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Zhang, Jiewu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Cheng, Ying[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Li, Zhendong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Liu, Hui[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17]

; Qin, Jianwu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Zhu, Jingqiang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ; Cheng, Ruochuan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17] ;

机构： [1]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China [2]Chinese Acad Med Sci, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China [3]Peking Union Med Coll, Beijing, Peoples R China [4]Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China [5]Univ Chinese Acad Sci, Zhejiang Canc Hosp, Zhejiang Prov Peoples Hosp,Chinese Acad Sci,Canc, Peoples Hosp,Hangzhou Med Coll,Inst Canc & Basic, Hangzhou, Peoples R China [6]Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Nanjing, Peoples R China [7]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China [8]Gansu Prov Canc Hosp, Lanzhou, Peoples R China [9]Hunan Canc Hosp, Changsha, Peoples R China [10]Harbin Med Univ, Canc Hosp, Harbin, Peoples R China [11]Jilin Canc Hosp, Changchun, Peoples R China [12]China Med Univ, Liaoning Tumor Hosp & Inst, Tumor Hosp, Shenyang, Peoples R China [13]Fujian Canc Hosp, Fuzhou, Peoples R China [14]Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China [15]Henan Canc Hosp, Zhengzhou, Peoples R China [16]Sichuan Univ, West China Hosp, Chengdu, Peoples R China [17]Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China

出处：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2019]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2018]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China [2]Chinese Acad Med Sci, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China [3]Peking Union Med Coll, Beijing, Peoples R China [4]Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China [5]Univ Chinese Acad Sci, Zhejiang Canc Hosp, Zhejiang Prov Peoples Hosp,Chinese Acad Sci,Canc, Peoples Hosp,Hangzhou Med Coll,Inst Canc & Basic, Hangzhou, Peoples R China [6]Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Nanjing, Peoples R China [7]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China [8]Gansu Prov Canc Hosp, Lanzhou, Peoples R China [9]Hunan Canc Hosp, Changsha, Peoples R China [10]Harbin Med Univ, Canc Hosp, Harbin, Peoples R China [11]Jilin Canc Hosp, Changchun, Peoples R China [12]China Med Univ, Liaoning Tumor Hosp & Inst, Tumor Hosp, Shenyang, Peoples R China [13]Fujian Canc Hosp, Fuzhou, Peoples R China [14]Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China [15]Henan Canc Hosp, Zhengzhou, Peoples R China [16]Sichuan Univ, West China Hosp, Chengdu, Peoples R China [17]Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup analysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC)

文献详情